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ABSTRACT
Chicken interleukin-1b (ChIL-1b) is synthesized as a precursor molecule that unlike its mammalian coun-
terpart, lacks a typical caspase-1 cleavage site. Therefore, it was unclear if proteolytic cleavage of ChIL-1b
can occur and if cleavage might modulate the biologic activity of this cytokine. Using an avian indicator cell
line that carries an NF-kB-regulated luciferase reporter gene, we established a sensitive and highly specific
bioassay for ChIL-1b. Experiments with a rabbit antiserum indicated that the NF-kB-stimulating activity in
supernatants of lipopolysaccharide (LPS)-treated chicken HD-11 macrophages is largely due to IL-1b and
that proteolytic processing of natural and recombinant ChIL-1b is not very efficient. Functional analyses fur-
ther revealed that cDNAs for either full-length or N-terminally truncated chicken ChIL-1b yielded active cy-
tokine. A truncated molecule that closely resembled putative mature ChIL-1b exhibited more than 100-fold
enhanced biologic activity after expression in mammalian cells, indicating that precursor cleavage is indeed
of critical importance for maximal activity.
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INTRODUCTION
MAMMALIAN INTERLEUKIN-1b (IL-1b) is an importantproinflammatory cytokine that exhibits pleiotropic activ-
ities on a wide range of target cells.(1) Biologic effects of IL-
1b include induction of fever, activation of the cytokine net-
work, triggering of the acute-phase response in the liver, and
activation of vascular endothelium. IL-1b further induces the
synthesis of CXC chemokines in fibroblasts and other cell
types.(2) It is secreted by many different cell types, with stim-
ulated macrophages being the main producers.(1) After binding
to a specific cell surface receptor, IL-1b activates a signal cas-
cade that causes nuclear localization of activated transcription
factor NF-kB and, consequently, enhanced transcription of a
large number of responsive genes.(3) IL-1b lacks a typical hy-
drophobic signal sequence at the N-terminus.(4) The primary
translation product is converted into mature cytokine by cas-
pase-1, a cysteinyl aspartate-specific proteinase.(5,6) The mech-
anism of IL-1b secretion is not fully understood.
Chicken IL-1b (ChIL-1b) is synthesized as a precursor mole-
cule that exhibits significant homology to mammalian IL-1b in
the C-terminal moiety.(7) Interestingly, the caspase-1 cleavage site
is not conserved in the chicken precursor. Nevertheless, bacteri-
ally produced recombinant ChIL-1b lacking the nonconserved N-
terminal part of the precursor molecule is biologically active,
demonstrating that the N-terminal moiety is dispensable.(7) Ex-
pression of the complete ChIL-1b cDNA in mammalian cells
yielded active cytokine, but the titers of such preparations were
low.(7) We reasoned that inefficient processing of the ChIL-1b
precursor limited the yields of active protein, but research aimed
at proving this hypothesis was slowed down because the previ-
ously available bioassay was laborious and impractical. It used
quail CEC-32 cells, which were stimulated with IL-1b before cy-
tokine-mediated accumulation of mRNA encoding the CXC
chemokine K60 was measured by Northern blotting.(7)
Here, we introduce a much simpler bioassay for ChIL-1b
that exhibits high sensitivity and high specificity. Using this as-
say, we show that N-terminal truncation of the ChIL-1b pre-
cursor near the putative protease cleavage site dramatically en-
hances cytokine activity.
1Department of Virology and 2Department of Microbiology, University of Freiburg, D-79104 Freiburg, Germany.
2Institute of Biochemistry, University of Szeged, H-6701 Szeged, Hungary.
3Institute of Animal Physiology, University of Munich, D-80539 Munich, Germany.
MATERIALS AND METHODS
Cells
Human 293T cells and quail CEC-32 cells,(8,9) permanently
transfected with an IL-1b responsive luciferase reporter gene
(CEC-NF-kB-LUC), were maintained in DMEM/NUT.Mix.F-
12 medium (Invitrogen, San Diego, CA) supplemented with
Glutamax and 10% fetal bovine serum (FBS).
Plasmids
The NF-kB-LUC reporter construct (PathDetect NF-kB) was
purchased from Stratagene (La Jolla, CA). The cDNA library
used for screening of clones encoding novel cytokines capable
of activating the CEC-NF-kB-LUC indicator cell line was con-
structed from mRNAs of lipopolysaccharide (LPS)-treated
chicken HD-11 cells as described.(7) Site-directed mutagenesis
of plasmid DNA was performed using the QuickChange kit
(Stratagene) and appropriate oligonucleotide primers as rec-
ommended by the manufacturer.
Antisera
Rabbits were immunized repeatedly with a bacterially pro-
duced, C-terminal fragment of ChIL-1b that roughly corresponds
to the putative mature form of this cytokine. This histidine-tagged
recombinant protein was produced and purified as described(7)
and emulsified in Freund’s incomplete adjuvant (FIA).
cDNA transfections
Plasmid DNA was purified from bacteria using a miniprep
kit (Peqlab, Erlangen, Germany). All transfections into 293T
cells were performed with Metafectene (Biontex, Munich, Ger-
many) following the protocol of the manufacturer. At 12 h post-
cDNA transfection, fresh medium with reduced content of FBS
(usually 2%) was added to the cultures, and supernatants were
harvested 48 h later. Where indicated, cell lysates were pre-
pared to analyze intracellular and extracellular ChIL-1b simul-
taneously. For this purpose, cells were lysed in the culture
medium by two cycles of freezing and thawing before cell de-
bris was removed by centrifugation.
Partial purification of natural ChIL-1b
Supernatant of HD-11 cells stimulated with LPS (1 mg/ml)
for 1 h and then cultivated in serum-free medium for another
3 h served as starting material for purification. Assuming that
ChIL-1b, like interferons (IFNs) and many growth factors,
would efficiently bind to controlled pore glass (CPG), HD-11
supernatant containing NF-kB-activating activity was loaded
onto a CPG column (0.7 g CPG per 100 ml supernatant). Sub-
sequently, the column was extensively washed with 50 mM
Tris-HCl, pH 7.2, containing 1 M NaCl before bound activity
was eluted with 500 mM Tris-HCl, pH 7.2, containing 1 M
NaCl. Further purification was achieved by ion exchange chro-
matography on MonoQ columns. Protein was loaded in 50 mM
Tris-HCl, pH 7.2, buffer, and contaminating proteins were
eluted with an increasing salt gradient. The NF-kB-activating
activity eluted at 110 mM NaCl. Molecular sieve chromatog-
raphy (Superdex 75 or TSK-Gel SW200) (Supelco, Bellefonte,
PA) showed a major protein peak of 50–60 kDa, frequently ac-
companied by a minor peak of approximately 20–25 kDa.
Bioassay for ChIL-1b
In standard assays, serial dilutions of cell lysates or cell
culture supernatants containing biologically active IL-1b
were added for 6 h to approximately 5 3 104 CEC-NF-kB-
LUC cells in 24-well plates. The medium was then removed,
and the cells were lysed with 100 ml lysis buffer (Promega,
Madison, WI). Samples were assayed for luciferase activity
using a kit (Promega).
The culture supernatants were depleted of biologically ac-
tive IL-1b as follows. The IgG fraction in 30-ml samples of
preimmune or hyperimmune serum was first immobilized on
protein A Sepharose beads. The washed beads were incubated
overnight with 300-ml samples of diluted, cytokine-contain-
ing cell culture medium. After removal of the beads by cen-
trifugation, the cleared samples were added to CEC-NF-kB-
LUC indicator cells for 6 h before luciferase activity was
determined.
Western blotting
Proteins in 50–100-ml samples of cell culture supernatants
or cell lysates were precipitated by adding ethanol to a final
concentration of 50% (v/v) and centrifuging. The dried pellet
was dissolved in SDS-PAGE sample buffer and heated to 95°C
for 5 min in the presence of 2-mercaptoethanol, and proteins in
the sample were subjected to 10% SDS-PAGE. Western blots
were probed with 0.1% rabbit hyperimmune serum in phos-
phate-buffered saline (PBS) containing 1% dry milk and de-
veloped using peroxidase-conjugated secondary antibody and
enhanced chemiluminescence (ECL) chemistry (Pierce, Rock-
ford, IL).
RESULTS
A simple bioassay for ChIL-1b
Assuming that ChIL-1b can activate a signaling cascade in
avian cells that causes the activation of transcription factor
NF-kB, we generated a stable CEC-32 quail cell clone that
expresses a firefly luciferase reporter gene under the control
of an NF-kB regulatory element. Incubation for 6 h of CEC-
NF-kB-LUC cells with supernatants of human 293T cells
transfected with an expression construct for ChIL-1b caused
10–20-fold enhanced luciferase activity (Fig. 1A). Luciferase
activity was gradually lost when increasing dilutions of su-
pernatant were used. Comparable luciferase induction rates
were measured if cytokine exposure was varied between 6 and
16 h (data not shown). When 293T supernatants containing
recombinant ChIL-1b were depleted with a rabbit antiserum
raised against a purified, bacterially expressed C-terminal
ChIL-1b fragment, luciferase activity was reduced to back-
ground levels (Fig. 1A), strongly suggesting that the active
factor was IL-1b. This view was further supported by the ob-
servation that supernatants of 293T cells transfected with the
empty vector contained no detectable NF-kB-stimulating ac-
tivity (data not shown).
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Antiserum to ChIL-1b blocks NF-kB-stimulating
activity in supernatants of Chicken HD-11 cells
Chicken HD-11 macrophages treated with LPS secrete IL-
1b and presumably several other cytokines.(10) Crude super-
natant of LPS-treated HD-11 cells strongly activated the NF-
kB-regulated luciferase reporter gene in CEC-NF-kB-LUC
cells. The material remained active if subjected to exhaustive
depletion with preimmune serum, but it was completely inac-
tivated even at low dilutions if subjected to depletion with an-
tiserum raised against ChIL-1b (Fig. 1B). We next purified the
NF-kB-stimulating activity by affinity chromatography on CPG
and showed that the activity of the purified material was also
efficiently neutralized by our rabbit antiserum but not by the
preimmune serum (Fig. 1C). From the titration curve, it can be
seen that the titer of the purified natural ChIL-1b preparation
dropped about 30-fold in the presence of antiserum, indicating
that either IL-1b alone or together with some other as yet un-
characterized, antigenically related proteins accounted for
.96% of the luciferase activity.
Poor cleavage of ChIL-1b precursor
Western blot analysis showed that the vast majority of ChIL-
1b in supernatants of transfected 293T cells was present as un-
cleaved 30-kDa precursor (Fig. 2A, lane 1). The two minor im-
munoreactive bands at approximately 15–17 kDa may represent
either correctly processed, mature ChIL-1b or inactive degra-
dation products. When partially purified, natural ChIL-1b was
analyzed by Western blotting, we observed two prominent im-
munoreactive bands at approximately 30 kDa and one at ap-
proximately 16 kDa (Fig. 2A, lane 2). They may represent the
uncleaved and caspase-cleaved forms of natural ChIL-1b, re-
spectively. It should be noted that the rather low amounts of
purified protein loaded in lane 2 were about 100-fold more 
active on CEC-NF-kB-LUC cells than the comparably high
amounts of recombinant protein loaded in lane 1, suggesting
that the specific biologic activity of natural ChIL-1b was at
least 1000-fold higher than that of the recombinant cytokine.
To determine if the rChIL-1b precursor would be processed
more efficiently in avian cells, we performed cDNA transfec-
tions into chicken HD-11 cells. Western blot analysis showed
that precursor processing was not more efficient in HD-11 cells
than in human 293T cells (Fig. 2B).
Specific response of CEC-NF-kB-LUC cells 
to ChIL-1b
To further characterize the NF-kB-stimulating cytokines se-
creted by LPS-treated HD-11 cells, we employed the bioassay
described to perform a functional screen of an appropriate
cDNA expression library.(7) Approximately 18,000 cDNAs,
represented by 150 pools comprising about 120 individual li-
brary plasmids each, were transfected into 293T cells before
the resulting supernatants were used to stimulate CEC-NF-kB-
LUC cells. About one third (52 of 150) of the cDNA pools were
positive in the initial screen. PCR with a primer pair that
matched ChIL-1b mRNA sequences flanking the initiation
codon revealed that 44 of the 52 positive pools contained at
least one ChIL-1b cDNA with complete coding information.
These pools were not characterized further. Seven of the eight
remaining pools contained at least one 59-terminally truncated
ChIL-1b plasmid similar to clone 16-16-9 (Fig. 3A). These 
cDNAs seemed to employ a second in-frame ATG codon at
amino acid position 46 for initiation of protein synthesis. West-
ern blot analysis (Fig. 2C, lane 3) confirmed that cDNA 16-16-
9 can direct the synthesis of an immunoreactive protein of ap-
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FIG. 1. Rabbit antiserum against a bacterially produced ChIL-
1b fragment blocks the activation of a luciferase reporter gene in
CEC-NF-kB-LUC indicator cells by (A) recombinant ChIL-1b
from transfected 293T cells, (B) crude natural ChIL-1b, or (C)
partially purified natural ChIL-1b. IgG in 30-ml samples of preim-
mune serum (circles) or hyperimmune serum (squares) was im-
mobilized on protein A Sepharose beads. Washed beads were in-
cubated overnight with 300-ml samples of cell culture medium
containing the indicated dilutions of either (A) recombinant ChIL-
1b derived from lysates of transfected 293T cells or (B) natural
ChIL-1b partially purified from supernatants of LPS-treated HD-
11 cells. After removal of the beads by centrifugation, the sam-
ples were added to CEC-NF-kB-LUC indicator cells for 6 h be-
fore luciferase activity was determined.
proximately 20 kDa in transfected 293T cells. It further yielded
an immunoreactive product of about 15 kDa. We did not try to
determine if it represents ChIL-1b that is cleaved correctly at
the putative processing site. The single remaining positive
cDNA pool yielded negative PCRs with all primers from re-
gions upstream of the putative proteolytic cleavage site of the
ChIL-1b precursor. After the active plasmid (80-11-12) in this
cDNA pool was identified by functional tests, we found that it
represented an IL-1b cDNA that was truncated immediately up-
stream of the putative protease cleavage site. This cDNA car-
ried the hexanucleotide ACGAGG at its 59-end (Fig. 3A), which
was presumably introduced artificially during cDNA cloning.
Thus, all biologically active cDNAs that we identified in this
screen were derived from the ChIL-1b gene. No cDNAs from
other chicken genes that might encode additional NF-kB-stim-
ulating proteins were found.
Greatly enhanced bioactivity of ChIL-1b artificially
processed to resemble putative mature cytokine
The biologically active cDNA clone 80-11-12 appeared to
code for only the C-terminal 97 amino acids of the ChIL-1b
precursor. It remained possible, however, that either the ACG
or the AGG codon at the 59-end of the plasmid insert served as
an alternative initiation codon. Western blot analysis failed to
provide evidence for this hypothesis (Fig. 2C, lane 2), indicat-
ing that if translation started at one of these two putative alter-
native sites, it did only with rather low efficacy. However, we
observed that if the AGG was mutated to a canonical ATG ini-
tiation codon, a high amount of immunoreactive protein of pre-
dicted size was present (Fig. 2C, lane 1). The various ChIL-1b
variants that we produced in transfected 293T cells all lacked
signal sequences that would facilitate their secretion into the
culture medium. Side-by-side titrations of supernatants and cell
lysates indicated that the bulk (.95%) of the NF-kB-stimulat-
ing activity remained inside the 293T producer cells (data not
shown). A comparison of the biologic activities of the various
IL-1b variants revealed that lysates of 293T cells transfected
with either full-length ChIL-1b, 16-16-9, or 80-11-12 cDNAs
contained comparable levels of NF-kB-stimulating activity,
whereas the activity in lysates of cells transfected with con-
struct ATG-80-11-12 was at least 100-fold enhanced (Fig. 3B).
Western blot analysis indicated that cells expressing either full-
length ChIL-1b cDNA or construct ATG-80-11-12 contained
comparable levels of recombinant IL-1b protein (Fig. 2C). In-
terestingly, 293T cells transfected with a ChIL-1b cDNA that
was truncated at its 59-end past the border of clone 80-11-12,
designated C-term, also contained low levels of biologic activ-
ity, whereas control cells transfected with the empty vector did
not (Fig. 3B). We concluded from these experiments that arti-
ficial truncation of the ChIL-1b precursor near the predicted
protease cleavage site dramatically increased its NF-kB-stimu-
lating activity. These data further indicated that the fairly high
biologic activity of clone 80-11-12 might be explained by as-
suming that a nonconventional initiation codon was used at low
efficacy to produce highly active ChIL-1b.
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FIG. 2. Western blot analysis of natural and recombinant ChIL-1b. Proteins in the various preparations were precipitated with
ethanol, dissolved in gel sample buffer, subjected to 15% SDS-PAGE, blotted to nylon membranes, and probed with rabbit an-
tiserum to bacterially produced ChIL-1b fragment. (A) Comparison of recombinant ChIL-1b in the supernatant of 293T cells
(lane 1) and natural ChIL-1b partially purified from supernatants of LPS-treated HD-11 cells (lane 2). (B) Analysis of ChIL-1b
precursor processing after transfection of ChIL-1b cDNA into either human 293T cells (lane 1) or chicken HD-11 cells (lane 2).
(C) Analysis of immunoreactive products present in 50-ml samples of lysates of 293T cells transfected with various forms of
ChIL-1b cDNA (see Fig. 3A). The gel positions of molecular weight markers are indicated.
DISCUSSION
The new bioassay for ChIL-1b that we introduced here is
based on the observation that signaling of IL-1b through its
cognate receptor results in rapid activation and nuclear translo-
cation of transcription factor NF-kB. The indicator cell line that
we used for our experiments carries an NF-kB-inducible lucif-
erase gene that permits a quick and highly sensitive readout.
This bioassay exhibits high selectivity for IL-1b. In a large
number of control experiments, we noted no unwanted back-
ground activity that may result from other factors present in
crude cell extracts. Importantly, our depletion experiments with
specific rabbit antiserum demonstrated that .96% of the NF-
kB-stimulating activity in supernatants of LPS-treated chicken
HD-11 cells was due to ChIL-1b or antigenically related mol-
ecules or both.
It is well known that activated HD-11 cells secrete a wide
range of cytokines, which all appeared to be inert in our assay.
In particular, they secrete IL-6, which is a potent activator of
NF-kB in B cells.(11) We found that ChIL-6 was not active in
our CEC-NF-kB-LUC indicator cell line (unpublished results),
presumably because CEC-32 cells lack IL-6 receptors. From
neutralization experiments with soluble chicken type I IL-1 re-
ceptor, other researchers concluded that about 30% of the IL-
1-like activity in supernatants of LPS-treated HD-11 cells is
probably caused by at least one other cytokine.(10) Obviously,
our new bioassay fails to pick up the activity of these other pu-
tative cytokines. Furthermore, our large functional screen of
cDNAs derived from LPS-treated chicken HD-11 cells suc-
cessfully identified many ChIL-1b clones but failed to identify
any other cytokine that would show activity in this assay. These
findings thus collectively show that the newly introduced bio-
assay for ChIL-1b exhibits a very high degree of specificity,
and they further indicate that chickens may have no functional
IL-1a homolog.
Sequence comparisons revealed that although the basic struc-
tures of chicken and mammalian IL-1b precursors are well con-
served, the caspase-1 cleavage site is not conserved.(7) The data
presented here nevertheless demonstrated that as in the case of
mammalian IL-1b, proteolytic processing greatly enhances the
biologic activity of the primary translation product of the ChIL-
1b cDNA. Thus, chicken caspase-1(12) may have a different
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FIG. 3. cDNA structures and biologic activities of several ChIL-1b variants. (A) Full-length ChIL-1b cDNA encodes a pre-
cursor protein of 267 amino acids. The putative protease cleavage site at position 107 and two in-frame translation initiation
codons are indicated. cDNA clones 16-16-9 and 80-11-12 were isolated in a functional screen. Clone ATG-80-11-12 was made
by converting the ACGAGG hexanucleotide at the 59-end of clone 80-11-12 to ACGATG, thus creating a canonical in-frame
translation initiation codon. The location of the 59-end of cDNA clone, C-term, is indicated. (B) 293T cells carrying the indi-
cated plasmids were lysed at 48 h posttransfection. A side-by-side comparison of the NF-kB-stimulating activity of the resulting
lysates in CEC-NF-kB-LUC cells at various dilutions is shown.
substrate specificity. Alternatively, other proteases might be re-
sponsible for cleavage of the IL-1b precusor. This would fit
with recent observations indicating that caspase-1 is also not
the sole caspase involved in mammalian IL-1b precursor pro-
cessing.(13) In this context, it is of interest to note that a large
fraction of the partially purified, natural ChIL-1b was present
in a noncleaved state (Fig 2A). This suggests that poor prote-
olytic processing might represent an intrinsic property of this
molecule. It is tempting to speculate that this property is im-
portant for the fine-tuning of the IL-1b activity in the chicken.
A final important aspect of our work should be mentioned.
We found a simple way to increase the notoriously low yields
of biologically active IL-1b in eukaryotic cells. Rather than ex-
pressing the full-length cDNA, we expressed only a fragment
encoding an N-terminally truncated molecule that almost pre-
cisely corresponds to the putative mature form of the cytokine.
Because such artificial molecules lack secretion signals, they
accumulate in the cytoplasm of the producer cells and have to
be released by cell lysis. Although this strategy bears the risk
of product degradation by nonspecific proteases, it obviously is
beneficial if natural product processing is inefficient. Future re-
search will need to show if this strategy can be used to increase
the biologic activity of other cytokines with similar needs for
posttranslational processing steps, as, for example, ChIL-18.(14)
This strategy could be used to equip viral vaccine vectors with
genes encoding biologically active ChIL-1b or ChIL-18.
ACKNOWLEDGMENT
Z.G. was supported by a short-term fellowship from the
Deutsche Forschungsgemeinschaft.
REFERENCES
1. DINARELLO, C.A. (1998). Interleukin-1, interleukin-1 receptors
and interleukin-1 receptor antagonist. Int. Rev. Immunol. 16,
457–499.
2. MUKAIDA, N., MAHE, Y., and MATSUSHIMA, K. (1990). Co-
operative interaction of nuclear factor-kB and cis-regulatory en-
hancer binding protein-like factor binding elements in activating
the interleukin-8 gene by proinflammatory cytokines. J. Biol.
Chem. 265, 21128–21133.
3. KUNO, K., and MATSUSHIMA, K. (1994). The IL-1 receptor sig-
naling pathway. J. Leukocyte Biol. 56, 542–547.
4. MARCH, C.J., MOSLEY, B., LARSEN, A., CERRETTI, D.P.,
BRAEDT, G., PRICE, V., GILLIS, S., HENNEY, C.S., 
KRONHEIM, S.R., GRABSTEIN, K., CONLON, P.J., HOPP,
T.P., and COSMAN, D. (1985). Cloning, sequence and expression
of two distinct human interleukin-1 complementary DNAs. Nature
315, 641–647.
5. CERRETTI, D.P., KOZLOSKY, C.J., MOSLEY, B., NELSON,
N., VAN NESS, K., GREENSTREET, T.A., MARCH, C.J., 
KRONHEIM, S.R., DRUCK, T., CANNIZZARO, L.A., HUEB-
NER, K., and BLACK, R.A. (1992). Molecular cloning of the in-
terleukin-1beta converting enzyme. Science 256, 97–100.
6. NICHOLSON, D.W., and THORNBERRY, N.A. (1997). Cas-
pases: killer proteases. Trends Biol. Sci. 22, 299–306.
7. WEINING, K.C., SICK, C., KASPERS, B., and STAEHELI, P.
(1998). A chicken homolog of mammalian interleukin-1 beta:
cDNA cloning and purification of active recombinant protein. Eur.
J. Biochem. 258, 994–1000.
8. KAADEN, O.R., LANGE, S., and STIBUREK, B. (1982). Estab-
lishment and characterization of chicken embryo fibroblast clone
LSCC-H32. In Vitro 18, 827–834.
9. ZOLLER, B., REDMAN-MULLER, I., NANDA, I., GUTTEN-
BACH, M., DOSCH, E., SCHMID, M., ZOOROB, R., and JUNG-
WIRTH, C. (2000). Sequence comparison of avian interferon reg-
ulatory factors and identification of the avian CEC-32 cell as a
quail cell line. J. Interferon Cytokine Res. 20, 711–717.
10. KLASING, K.C., and PENG, R.K. (2001). Soluble type-I inter-
leukin-1 receptor blocks chicken IL-1 activity. Dev. Comp. Im-
munol. 25, 345–352.
11. SCHNEIDER, K., KLAAS, R., KASPERS, B., and STAEHELI,
P. (2001). Chicken interleukin-6. cDNA structure and biological
properties. Eur. J. Biochem. 268, 4200–4206.
12. JOHNSON, A.L., BRIDGHAM, J.T., MUNKS, M., and WITTY,
J.P. (1998). Characterization of the chicken interleukin-1beta con-
verting enzyme (caspase-1) cDNA and expression of caspase-1
mRNA in the hen. Gene 219, 55–62.
13. BURNS, K., MARTINON, F., and TSCHOPP, J. (2003). New in-
sights into the mechanism of IL-1beta maturation. Curr. Opin. Im-
munol. 15, 26–30.
14. SCHNEIDER, K., PUEHLER, F., BAEUERLE, D., ELVERS, S.,
STAEHELI, P., KASPERS, B., and WEINING, K.C. (2000).
cDNA cloning of biologically active chicken interleukin-18. J. In-
terferon Cytokine Res. 20, 879–883.










Received 13 January 2003/Accepted 25 February 2003
GYORFY ET AL.228
